Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-106.08%
↓ 157% below average
Average (9y)
185.23%
Historical baseline
Range
High:1140.37%
Low:-106.08%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -106.08% |
| 2023 | -11.04% |
| 2022 | 54.83% |
| 2021 | -2.60% |
| 2020 | 138.51% |
| 2019 | 88.55% |
| 2018 | 415.36% |
| 2017 | 1140.37% |
| 2016 | 102.12% |
| 2015 | 32.31% |